Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 19.97M P/E - EPS this Y 44.40% Ern Qtrly Grth -
Income -37.94M Forward P/E -0.74 EPS next Y 27.60% 50D Avg Chg -34.00%
Sales - PEG - EPS past 5Y - 200D Avg Chg -19.00%
Dividend N/A Price/Book 0.58 EPS next 5Y - 52W High Chg -52.00%
Recommedations 1.70 Quick Ratio 0.58 Shares Outstanding 29.67M 52W Low Chg 49.00%
Insider Own 18.06% ROA -74.06% Shares Float 23.31M Beta 1.15
Inst Own 37.10% ROE -224.18% Shares Shorted/Prior 403.02K/433.17K Price 0.94
Gross Margin - Profit Margin - Avg. Volume 87,761 Target Price 7.00
Oper. Margin - Earnings Date Aug 5 Volume 163,146 Change -7.84%
About Vincerx Pharma, Inc.

Vincerx Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops therapies to address unmet medical needs for the treatment of cancer in the United States. The company is developing enitociclib, a cyclin-dependent kinase-9 inhibitor that is in Phase 1 clinical trials for treating patients with relapsed and refractory leukemia and lymphoid malignancies, as well as solid tumors and non-Hodgkin lymphoma; and VIP236, a small molecule drug conjugate that is in Phase 1 clinical trials to treat advanced or metastatic solid tumors. Its product candidates also include VIP943 in Phase 1 clinical trials for the treatment of relapsed/refractory acute myeloid leukemia, myelodysplastic syndrome, and B-cell acute lymphoblastic leukemia; and VIP924 in preclinical studies for the treatment of B-cell malignancies. Vincerx Pharma, Inc. was founded in 2019 and is based in Palo Alto, California.

Vincerx Pharma, Inc. News
11:00 AM Vincerx Pharma (VINC) Moves to Buy: Rationale Behind the Upgrade
05/14/24 Vincerx Pharma Reports First Quarter 2024 Financial Results and Provides Corporate Update
04/25/24 Vincerx Pharma Announces Pricing of Underwritten Public Offering of Common Stock and Warrants
04/25/24 Vincerx Pharma Announces Proposed Underwritten Public Offering of Common Stock and Warrants
04/09/24 Vincerx (VINC) Tumbles on Results From Cancer Therapy Study
04/09/24 Why Is Small-Cap Cancer Focused Vincerx Pharma Stock Plummeting On Tuesday?
04/08/24 Vincerx Pharma Presents Positive Preliminary Phase 1 Data for VIP236 and Updates on Pipeline Progress at the American Association for Cancer Research (AACR) Annual Meeting 2024
04/01/24 Vincerx to Host Virtual Investor Event Reviewing Preliminary Phase 1 VIP236 Data Presented at the American Association for Cancer Research (AACR) Annual Meeting 2024
03/29/24 Vincerx Pharma Inc (VINC) Reports Q4 and Full Year 2023 Financials: A Close Look
03/29/24 Vincerx Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Update
03/14/24 12 Most Profitable Biotech Stocks To Invest In
03/05/24 Vincerx to Present Three Posters at the American Association for Cancer Research (AACR) Annual Meeting 2024
03/05/24 Vincerx Pharma, Inc.'s (NASDAQ:VINC) large institutional owners must be happy as stock continues to impress, up 28% over the past week
01/07/24 Vincerx Pharma Announces Compelling Clinical Efficacy of Enitociclib in Combination with Venetoclax and Prednisone in Lymphoma
12/19/23 15 Best Falling Stocks To Buy Now
12/10/23 Vincerx Pharma Presents Preclinical VIP943 and VIP924 Posters at ASH 2023
11/14/23 Vincerx Pharma Reports Third Quarter 2023 Financial Results and Provides Corporate Update
11/02/23 Vincerx Pharma To Present Three Posters at ASH 2023 in December
10/13/23 New to The Street Airs Televised Corporate Interviews Episodes 521 and 522 as Sponsored Programming on Bloomberg TV and The Fox Business Network
10/06/23 New to The Street Announces TV Corporate Appearances, Broadcasting Episode 518 on Newsmax and Episode 519 on FOX Business Network, Airings start on Saturday, October 7, 2023, at 3:30 PM ET
VINC Chatroom

User Image BioAmerica Posted - 58 minutes ago

$VINC The children here are destroying yet another message board. You can tell the real investors from the children by who posts what. I just put the serial picture posters on "Block" and move on. My bet is I have the largest Block list on ST. As for VINC, I have a large and growing position as part of a speculative biotech portfolio. I like the management but understand the need for cash to keep things going. I use their offerings as a chance to buy cheaper. This will be a successful company. It may just take awhile.

User Image Andysss Posted - 1 hour ago

$VINC New to this page. See there is a lot of GIFs and stickers but little substance. What do you expect to see in the data update for VIP 236? Better responses? Not realistic. My main worry is their limited cash runway. Bull on ADC’s. Have a small position in VINC ,but unsure how to play it.

User Image S_Franconi Posted - 22 hours ago

$VINC

User Image SeekingOctane Posted - 23 hours ago

Looks like a rotation back into Antibody Drug Conjugate stocks: $STRO $PYXS $VINC

User Image CON_or_McGregor Posted - 1 day ago

$VINC

User Image GSHSRWD Posted - 1 day ago

$VINC

User Image moslofu Posted - 1 day ago

$VINC anyone have a reference for when the next set of test results are released? Heard end of August maybe?

User Image SeekingOctane Posted - 1 day ago

Adc stocks heating up $VINC

User Image SeekingOctane Posted - 1 day ago

$VINC Trodelvy = SMDC vip236

User Image RamenLives Posted - 2 days ago

$VINC Give me .66 and I'm in

User Image CON_or_McGregor Posted - 2 days ago

$VINC

User Image GSHSRWD Posted - 2 days ago

$VINC I said square pizza . Round pizza is for freebirds. We’re locked up

User Image SeekingOctane Posted - 2 days ago

$VINC Big move coming.

User Image GSHSRWD Posted - 2 days ago

$VINC square pizza day here

User Image stevelue Posted - 2 days ago

$VINC already Double the avg Volume with 1.4 hrs to go..Accumulation happening

User Image Zipp3001 Posted - 2 days ago

$VINC nothing’s gonna happen to after the meeting in August when they repriced the options. I highly doubt they’re gonna release data and shoot the stock price up.

User Image stevelue Posted - 2 days ago

$VINC a new Uptrend has begun here

User Image SeekingOctane Posted - 3 days ago

Launch Mode time.. get long! $VINC

User Image SeekingOctane Posted - 3 days ago

$VINC Been a wild ride. Expecting the group that ran it up to push it up again before data end of August. Huge gains!

User Image stevelue Posted - 3 days ago

$VINC the 50 day Mov avg is close at .06685....

User Image stevelue Posted - 3 days ago

$VINC looks like a new Uprend is just starting here now imo

User Image Mattcal44 Posted - 3 days ago

$VINC

User Image GSHSRWD Posted - 3 days ago

$VINC

User Image S_Franconi Posted - 3 days ago

$VINC

User Image CON_or_McGregor Posted - 4 days ago

$VINC cmon manggggg

User Image SeekingOctane Posted - 4 days ago

$VINC $CRWD Crowdstrike could lose all their referrals from AWS and Azure which account for 50% of their business. vincerx has 10x upside similar to Tridelvy same sn38 warhead as what Immunomedics sold to Gilead for $21 billion. Hamdy at Vincerx was cmo at Pharmacyclics and CEO of Acerta which equated to $28 billion in takeovers alone.

User Image GSHSRWD Posted - 4 days ago

$VINC happy Monday from the can

User Image SeekingOctane Posted - 4 days ago

$VINC Get on the inside track with management’s repricing….

User Image SeekingOctane Posted - 4 days ago

$VINC Management repricing options before launch mode!

User Image Investogater Posted - 4 days ago

$VINC VINC is going to get rid of these nasty tumors! Invest now, great entry point......

Analyst Ratings
Cantor Fitzgerald Overweight Apr 9, 24
Cantor Fitzgerald Overweight Apr 1, 24
Cantor Fitzgerald Overweight Sep 7, 23
Chardan Capital Buy Nov 17, 22
SVB Leerink Outperform Aug 12, 22
Cantor Fitzgerald Overweight Jun 8, 22
B. Riley Securities Buy Jun 7, 22
Chardan Capital Buy Jun 7, 22
SVB Leerink Outperform Jun 7, 22
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Hamdy Ahmed MD See Remarks See Remarks Aug 09 Buy 0.95 22,300 21,185 96,060 08/10/23
THOMAS TOM C See Remarks See Remarks Aug 10 Buy 0.95 5,000 4,750 219,935 08/10/23
Izumi Raquel E. See Remarks See Remarks Aug 09 Buy 0.92 16,476 15,158 85,214 08/10/23
Izumi Raquel E. See Remarks See Remarks Dec 14 Buy 0.8848 28,738 25,427 68,738 12/14/22
Hamdy Ahmed MD Chief Executive Offi.. Chief Executive Officer Dec 14 Buy 0.8656 35,280 30,538 73,760 12/14/22
THOMAS TOM C See Remarks See Remarks Dec 14 Buy 0.83 7,000 5,810 10,000 12/14/22
Hamdy Ahmed MD Chief Executive Offi.. Chief Executive Officer Jun 23 Buy 1.4106 24,200 34,137 38,480 06/27/22
Bushnell Laura I. Director Director Jun 09 Buy 1.9083 15,000 28,624 19,202 06/13/22